Increased Mortality of Patients With Diabetes Reporting Severe Hypoglycemia
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Hypoglycemia is a cause of significant morbidity among patients with diabetes and may be associated with greater risk of death. We conducted a retrospective study to determine whether patient self-report of severe hypoglycemia is associated with increased mortality. RESEARCH DESIGN AND METHODS: Adult patients (N = 1,020) seen in a specialty diabetes clinic between August 2005 and July 2006 were questioned about frequency of hypoglycemia during a preencounter interview; 7 were lost to follow-up and excluded from analysis. Mild hypoglycemia was defined as symptoms managed without assistance, and severe hypoglycemia was defined as symptoms requiring external assistance. Mortality data, demographics, clinical characteristics, and Charlson comorbidity index (CCI) were obtained from the electronic medical record after 5 years. Patients were stratified by self-report of hypoglycemia at baseline, demographics were compared using the two-sample t test, and risk of death was expressed as odds ratio (95% CI). Associations were controlled for age, sex, diabetes type and duration, CCI, HbA1c, and report of severe hypoglycemia. RESULTS: In total, 1,013 patients with type 1 (21.3%) and type 2 (78.7%) diabetes were questioned about hypoglycemia. Among these, 625 (61.7%) reported any hypoglycemia, and 76 (7.5%) reported severe hypoglycemia. After 5 years, patients who reported severe hypoglycemia had 3.4-fold higher mortality (95% CI 1.5–7.4; P = 0.005) compared with those who reported mild/no hypoglycemia. CONCLUSIONS: Self-report of severe hypoglycemia is associated with 3.4-fold increased risk of death. Patient-reported outcomes, including patient-reported hypoglycemia, may therefore augment risk stratification and disease management of patients with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The primary cause of hypoglycemia is intensification of antihyperglycemic therapy (almost always using SUs [or to a lesser extent glinides] and/or insulin) aimed at achieving lower A1C targets, as demonstrated by intensive therapy trials.1202,1203”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1202]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [195]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An association between selfreported level 3 hypoglycemia and 5-year mortality has also been reported in clinical practice (91).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [91]
The cited source says what the claim attributes to it.
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial and in clinical practice (77,78).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587 · cited 1×
“The CCI is an extensively studied and widely used measure that weighs comorbid conditions by the strength of their association with 1-year mortality (17,18); it has been previously validated for use in diabetes (19).”
BackgroundIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Cited by
Items 401–500 of 541
Rode, M. M., Boggust, B., Manggaard, J. M., Myers, L. A., Swanson, K. M., & McCoy, R. G. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111741 · Cited by 5
Self-citationClinical Characteristics of Subjects with Sulfonylurea-Dependent Type 2 Diabetes
Min, S. H., Kwak, S. H., Cho, Y. M., Park, K. S., & Jung, H. S. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.4.509 · Cited by 3
Ashoor, M., Bintouq, A. K., Rutter, M. K., & Malik, R. A. (2016) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2016.06.003 · Cited by 3
Iloh, G. U. P., & Collins, P. (2017) · BLDE University Journal of Health Sciences · doi:10.4103/bjhs.bjhs_5_17 · Cited by 5
“However, iatrogenic hypoglycemia resulting from overzealous effort to achieve tight glycemic control has been reported in biomedical literature in different parts of the world,[14‐19] and this could be potentially harmful with fatal[21,22] and nonfatal outcomes such as cardiac arrhythmias and ischemia,[23] hypoglycemi…”
BackgroundMin, J. Y., Hackstadt, A. J., Griffin, M. R., Greevy, R. A., Chipman, J., Grijalva, C. G., Hung, A. M., & Roumie, C. L. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13846 · Cited by 3
“It remains unclear whether weight gain and hypoglycaemia are potential mediators or markers of other unmeasured conditions that lead to death.(13,14) The aim of this study was to use mediation analysis methods to evaluate whether two potentially important mediators – weight change and hypoglycaemia – could explain som…”
Tuháčková, M., Urbanová, J., Brunerová, L., Piťhová, P., Kvapil, M., & Brož, J. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.053 · Cited by 3
Non-insulin therapies in addition to insulin in Type 1 DM treatment
Llano, A., & McKay, G. A. (2020) · British Medical Bulletin · doi:10.1093/bmb/ldaa011 · Cited by 3
Clinical features and treatment of coronary heart disease in diabetes
Standl, E., Erbach, M., Hanefeld, M., Schnell, O., Stratmann, B., & Tschoepe, D. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch73 · Cited by 3
Mughal, M. A., Mahmood, K., Ramzan, M., Arshad, A., Faurooqi, M. Z. U. R., Hussain, M., Hanif, M., & Amara, U. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.118069 · Cited by 2
Yale, J., Osumili, B., Mitchell, B. D., Hunt, B., Sohi, G., Jeddi, M., Mojdami, D., & Valentine, W. J. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2035131 · Cited by 2
Boynton, M. H., Donahue, K. E., Richman, E. L., Johnson, A., Leeman, J., Vu, M. B., Rees, J. R., & Young, L. (2022) · Clinical Diabetes · doi:10.2337/cd21-0141 · Cited by 2
Oraibi, O., Alameer, A., Dalak, M., Alsharif, S., Hakami, S. A., Sumayli, M. A. A., Shami, A., Mohrag, M., Madkhali, M. A., Madkhali, M. A., et al. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998288242240104054438 · Cited by 2
Ralston, J. D., Anderson, M. L., Ng, J., Bashir, A., Ehrlich, K. J., Burns-Hunt, D., Cotton, M., Hansell, L. D., Hsu, C. W., Hunt, H., et al. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107456 · Cited by 2
Hypoglycemia in Critically Ill Patients
Ma, T., & Chen, L. L. (2024) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000525 · Cited by 2
Hannah, K. L., Nemlekar, P. M., Bushman, J. S., & Norman, G. J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15982 · Cited by 2
Severe hypoglycemia and cardiovascular disease
Tak, S., & Jain, A. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100357 · Cited by 2
Ooi, S.-W., Yeh, S., Chang, Y., Li, C., & Chen, H.-F. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288360 · Cited by 3
“On the contrary, patients with self-reported severe hypoglycemia in Mayo’s clinic’s study [2] increased the odds of death (OR: 3.”
BackgroundResultInfluentialWelford, A. E., Ridgeway, J., Gillies, C., Choudhary, P., Hegde, V., Khunti, K., & Seidu, S. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01740-9 · Cited by 2
“Hospitalisation for hypoglycaemia is associated with cardiovascular events, falls and fractures, death, cognitive complications, reduced quality of life, and poor prognosis [5, 8, 9].”
Learning About New Therapies: Phase 3 Clinical Studies—And Beyond
Riddle, M. C. (2013) · Diabetes Care · doi:10.2337/dc13-1019 · Cited by 2
Boutayeb, W., Lamlili, M. E. N., Mostafa, S. B. E., Zitouni, N., & Boutayeb, A. (2015) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-150045 · Cited by 2
“The authors confirm that the”
Hypoglycemic Morbidity and Mortality in Diabetes
Son, J. W. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.1.17 · Cited by 2
“38로, 저혈당 발생의 과거력이 없는 환자들과 비교하여 유의하게 높았다[18].”
Nishtala, P. S., & Salahudeen, M. S. (2016) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098616660948 · Cited by 2
Pereira, C. A., Almeida, R., & Dores, J. M. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.150 · Cited by 2
Liu, S., Columbus, M. P., Peddle, M. B., Mahon, J. L., & Spaic, T. (2021) · CMAJ Open · doi:10.9778/cmajo.20200184 · Cited by 2
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_22-2 · Cited by 2
Islet Cell or Pancreas Transplantation
Piemonti, L., Socci, C., Nano, R., Maffi, P., & Secchi, A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_23-1 · Cited by 2
Diabetisches Koma und perioperative Diabetestherapie
Berndt, M., Klose, S., & Lehnert, H. (2014) · Springer eBooks · doi:10.1007/978-3-642-54953-3_67 · Cited by 2
George, M. P., Zilbermint, M. F., Sokolinsky, S., Batty, K., Motevalli, M., Stanback, C., Gonzales, E., Miller, C., Sequeira, L., & Demidowich, A. P. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111785 · Cited by 2
Amoura, L., El-Ghazouani, F., Kassem, M., Habhab, A. E., Kreutter, G., Sahraoui, S., Bosco, D., Benkirane-Jessel, N., Berney, T., Benhamou, P., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15534 · Cited by 8
The current state of pancreas transplantation in the United States—A registry report
Gruessner, A. C., & Gruessner, R. W. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00028-9 · Cited by 2
Iatrogenic hypoglycemia and quality of life in patients with type 2 diabetes mellitus
Vellanki, P., & Umpierrez, G. E. (2015) · Revista Clínica Española · doi:10.1016/j.rce.2014.11.017 · Cited by 2
“Iatrogenic hypoglycemia represents a significant cause of morbidity and mortality in patients with type 1(9) and type 2 diabetes.(10,11) In ADVANCE and ACCORD studies, severe hypoglycemia was associated with significant risk increases for cardiovascular events and mortality.”
BackgroundMarathe, C. S., Phillips, L. K., & Horowitz, M. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch64 · Cited by 2
Endocrine-enriched stem cell-derived islets improve long-term safety in vivoPreprint
Setyono, E. S. A., Rogers, N. K., Scheibner, K., Schirge, S., Reich, H., Sterr, M., Öztürk, T., Franzenburg, S., Lithovius, V., & Lickert, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.22.671768 · Cited by 4
Hypoglycemia in Pancreatic Disease
Mordes, M. J. T. A. J. P. (2015) · doi:10.3998/panc.2015.11 · Cited by 3
“Severe hypoglycemia is associated with increased mortality in diabetic patients (23).”
BackgroundTelephone advice on first aid in hypoglycemia: Developing an evidence‐based dispatcher algorithm
Birkun, A. A. (2024) · Academic Emergency Medicine · doi:10.1111/acem.14977 · Cited by 1
Aung, N. L. (2025) · Clinical Diabetes · doi:10.2337/cd25-0072 · Cited by 2
Zhang, Y., Hu, X., Xu, W., Chen, Y., Guo, X., Liu, S.-H., & Gao, L. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i9.104290 · Cited by 1
Pancreas Transplantation Alone for Brittle Diabetes Mellitus
Gruessner, R. W. G. (2023) · ES Journal of Case Reports · doi:10.59152/esjcr/1044 · Cited by 1
Diabetes Management in the Emergency Department
Gottlieb, D., Silverman, R., & Schulman‐Rosenbaum, R. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_11 · Cited by 1
Russell-Jones, D. L., Bailey, T. S., Lane, W. S., Mathieu, C., & Pedersen‐Bjergaard, U. (2024) · Diabetic Medicine · doi:10.1111/dme.15339 · Cited by 1
Estimation of HbA1c and Impact of Continuous Glucose Monitoring in Hypoglycemic States
Mishra, B. K., Raghav, A., Jeong, G., Jain, M. K., Shukla, P., & Sharma, S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005805 · Cited by 2
Mooradian, A. D. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00685-x · Cited by 1
Liu, D., Li, N., Zhu, Y., Chen, Q., & Feng, J. (2025) · BMC Neurology · doi:10.1186/s12883-025-04077-9 · Cited by 1
“Clinically, this distinction is significant as it underscores the potential dangers of overly aggressive glucose-lowering strategies, particularly in older adults or individuals with a history of cerebrovascular disease [30, 31].”
Diabetisches Koma und perioperative Diabetestherapie
Klose, S., & Lehnert, H. (2004) · Springer eBooks · doi:10.1007/978-3-662-06654-6_51 · Cited by 1
Diabetes mellitus tipo 2 en el paciente anciano institucionalizado
Megías, M. C., & Guisado‐Vasco, P. (2014) · Revista Clínica Española · doi:10.1016/j.rce.2014.02.004 · Cited by 2
Type 2 diabetes mellitus in elderly institutionalized patients
Megías, M. C., & Vasco, P. G. (2014) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2014.02.003 · Cited by 2
Kim, E. J., Jeong, M. H., Jeong, I. S., Oh, S. G., Kim, S. H., Ahn, Y. K., Kim, J. H., Kim, Y. J., Chae, S. C., Hong, T. J., et al. (2014) · Korean Journal of Medicine · doi:10.3904/kjm.2014.87.5.565 · Cited by 1
“- 571 혈관사건을 증가시킨다고 할 수 있다[24,25].”
Glucose, cholesterol, and blood pressure: is lower always better for type 2 diabetes?
Giugliano, D., Maiorino, M. I., Bellastella, G., & Esposito, K. (2016) · Endocrine · doi:10.1007/s12020-016-0981-y · Cited by 2
“These trials also found an increased hypoglycemic risk with intensive treatment, which is associated with adverse health outcomes [17], although causality is unproven.”
BackgroundIslet Cell or Pancreas Transplantation
Piemonti, L., Socci, C., Nano, R., Maffi, P., & Secchi, A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_23 · Cited by 2
Kang, H. J., Lee, H., Park, E. M., Kim, J. M., Shin, J., & Park, C. (2018) · Xenotransplantation · doi:10.1111/xen.12384 · Cited by 1
Special Considerations in the Management and Education of Older Persons With Diabetes
Mobley-Bukstein, W., Reece, S. W., & Hebdon, K. (2021) · ADCES in Practice · doi:10.1177/2633559x211015972
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_22 · Cited by 3
Galea, A., Farrugia, S., Calleja, N., & Coppini, D. (2022) · Practical Diabetes · doi:10.1002/pdi.2415 · Cited by 1
Practical guide in using insulin degludec/insulin aspart: A multidisciplinary approach in Malaysia
Chan, S. P., Mumtaz, M., Ratnasingam, J., Tan, A. T. B., Lim, S. C., Rosman, A., Chee, K. H., Lim, S. K., Yew, S. S., Yusof, B. N. M., et al. (2023) · Malaysian Family Physician · doi:10.51866/cpg.255 · Cited by 1
Dei, A., Aldigeri, R., Bellei, G., Raffaeli, D., Bartolo, P. D., Sforza, A., Marchesini, G., Ciardullo, A. V., Manicardi, V., Bianco, M., et al. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02298-x · Cited by 2
“The reduction in hypoglycemic events -obtained in the contest of a Regionwide reimbursement-is of extreme clinical relevance in relation to the robust association between hypoglycemic events and increased morbility and mortality in T1D [5, 26–28].”
BackgroundInfluentialPost-hypoglycemic nocturnal hyperglycemia in type 1 diabetes: the Somogyi hypothesis revisited
González‐Vidal, T., Rivas‐Otero, D., Agüeria‐Cabal, P., Ramos‐Ruiz, G., Lambert, C., Ares, J., Torre, E. L. M., & Delgado, E. (2025) · HORMONES · doi:10.1007/s42000-025-00680-0 · Cited by 2
Hypoglycemia, Arrythmia and Mortality in Diabetes, an underestimated risk?
Kasperek, B., Tymoszuk, P., Augustowska, K., Żak-Gontarz, A., Sierzpowski, R., Protasiuk, A., Loryś, L., Klimczak, K., & Budzyńska, K. (2025) · Quality in Sport · doi:10.12775/qs.2025.42.61151 · Cited by 1
Dagogo-Jack, S. E. (2012) · Evidence-Based Nursing · doi:10.1136/eb-2012-101111 · Cited by 1
Bordier, L., Dolz, M., Sollier, M., Garcia, C., Doucet, J., Verny, C., Floch, J. P. L., & Bauduceau, B. (2018) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(18)89308-4 · Cited by 1
Peng, M., Yuan, S., Shi, X., & Lu, X. (2019) · Journal of Applied Polymer Science · doi:10.1002/app.47933 · Cited by 1
Current view of treatment of hypoglycemia
Brož, J., Urbanová, J., Nunes, M. A., Tuháčková, M., Brunerová, L., & Žďarská, D. J. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.051 · Cited by 5
Feldman, H. A. (2020) · Physician Assistant Clinics · doi:10.1016/j.cpha.2019.12.001 · Cited by 1
LACY, M. E., Whitmer, R. A., Lee, S. J., Rushakoff, R. J., & Pletcher, M. J. (2021) · Clinical Diabetes · doi:10.2337/cd20-0057 · Cited by 1
Dumber, D. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i4.12266 · Cited by 1
Circumventing immune rejection and foreign body response to therapeutics of type 1 diabetes
Bauer, S. J., & Doloff, J. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821440-4.00006-2 · Cited by 2
Pickup, J. C. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_22-1 · Cited by 1
Lablanche, S., Camille, L., & Benhamou, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-98119-2_7 · Cited by 1
Glycemic control metrics for in silico testing of artificial pancreas systems
Novák, K., Kovács, L., Drexler, D. A., & Eigner, G. (2022) · IEEE International Symposium on Computational Intelligence and Informatics (CINTI) · doi:10.1109/cinti-macro57952.2022.10029513 · Cited by 1
“Patients at risk of severe hypoglycemia have an increased mortality rate [26], [27]; therefore, minimizing glycemic variability should be a key aspect of glycemic control.”
BackgroundPancreas Transplantation Alone
Gruessner, R. W. G., & Gruessner, A. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_24 · Cited by 1
Postmortem biochemistry - analysis of metabolic imbalance
Keltanen, T. (2015) · Helda - University of Helsinki Institutional Repository · Cited by 3
Cryer, P. E. (2013) · Diabetes Care · doi:10.2337/dc12-2253 · Cited by 1
Argente, M. (2020) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · doi:10.6035/14112.2020.579334 · Cited by 1
Şimşek, Y., & Urhan, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103112 · Cited by 2
Munshi, M. N. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch24 · Cited by 2
Can Islet Transplantation Possibly Reduce Mortality in Type 1 Diabetes
Isenberg, J. S., & KANDEEL, F. R. (2025) · Cell Transplantation · doi:10.1177/09636897241312801 · Cited by 1
Glycemic treatment of diabetes mellitus
Kaur, H., & Weinstock, R. S. (2014) · Wiley eBooks · doi:10.1002/9781118887837.ch4
Obesity and co-morbidities in type 2 diabetes: An opportunity to bend the Health Care Cost Curve
Kristensen, T., & Yderstræde, K. B. (2014) · Revista Clínica Española · doi:10.1016/j.rce.2014.01.003
Penfornis, A., Bourdel‐Marchasson, I., Quéré, S., & Dejager, S. (2014) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(14)70681-9
Benzinger, P., Ahmed, M. S., & Abbatecola, A. M. (2014) · European Geriatric Medicine · doi:10.1016/j.eurger.2014.04.008
Le diabète de type 2 au stade de l’insuline : Quelle place pour les inhibiteurs de la DPP-4 ?
Halimi, S., Charbonnel, B. H., Monguillon, P., & Dejager, S. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30011-0 · Cited by 1
Intranasale Applikation von Glukagon zur Behandlung der insulininduzierten Hypoglykämie
Spranger, S. (2016) · Der Diabetologe · doi:10.1007/s11428-016-0086-5
Fah, T. S. (2016) · Medicine & health · doi:10.17845/mh.2016.1101.10
“Severe hypoglycaemia is associated with a 3-fold increased risk of mortality compared to non-severe hypoglycaemia (McCoy et al. 2012).”
BackgroundSudulagunta, S. R., Kumar, B. R. S., Sodalagunta, M. B., Khorram, H., Sepehrar, M., & Noroozpour, Z. (2016)
Nationwide reduction in the frequency of severe hypoglycemia by half
Italia, S.-V. (2015)
Wojtusciszyn, A. (2017) · doi:10.1016/b978-2-294-74646-8.00026-2
Mehr als nur Blutzucker — was für Neurologen und Psychiater wichtig ist
Eschle, D., & Hurni, A. (2017) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-017-1823-3
“— Das oberste ´erapieprinzip ist die Vermeidung von Hypoglykämien in allen Lebenslagen – in und außerhalb des Krankenhauses.”
BackgroundInfluentialPickup, J. C. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.2503
Walkinshaw, E. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
GLYCAEMIA SELF-CONTROL ROLE IN PREVENTION OF CARDIOVASCULAR DISEASES IN DIABETES MELLITUS PATIENTS
Shatskaya, O. A., & Kukharenko, S. S. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-11-166-169
Coutant, R., Tubiana‐Rufi, N., Leroy, C., Lefebvre, C., Gueorguieva, I., Cartigny, M., Lablanche, S., & Benhamou, P. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-74942-1.00012-4
Colombat, S., & Boulin, M. (2019) · Therapies · doi:10.1016/j.therap.2019.09.002
Uduku, C. N., Reddy, M., & Oliver, N. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00007-7
Le glucagon nasal, une innovation bien sentie
Benhamou, P. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.07.005 · Cited by 1
On the Origin of Morphological Structures of Planetary Nebulae
Kwok, S. (2011) · The HKU Scholars Hub (University of Hong Kong)
Raffali, M. A., Muhammad, S., Hamid, H. A., Nawi, A., & Kamaruddin, N. (2021) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.036.01.15
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_22-1 · Cited by 2
Forde, H. E., Wilmot, E. G., & Choudhary, P. (2021) · Diabetic Medicine · doi:10.1111/dme.14546
Pickup, J. C. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_22
Diabetisches Koma und perioperative Diabetestherapie
Berndt, M., Klose, S., & Lehnert, H. (2015) · Springer eBooks · doi:10.1007/978-3-642-54675-4_78-1
Metadata
- Authors
- McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A.
- Affiliations
- Mayo Clinic (US)
- Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
- Corresponding author
- Smith, Steven A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-08-14
- Volume
- 35
- Issue
- 9
- Pages
- 1897-1901
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3425008
- OpenAlex
- W2153957843
- Semantic Scholar
- 28fffca9598fb24277bf9ea60849e4ad6060f499
- Cited by
- 539
- References
- 32
- Citations by year
- 2026: 16 · 2025: 20 · 2024: 34 · 2023: 37 · 2022: 46 · 2021: 35 · 2020: 46 · 2019: 59 · 2018: 36 · 2017: 43 · 2016: 50 · 2015: 49 · 2014: 39 · 2013: 24 · 2012: 3
- FWCI
- 29.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- severe hypoglycemia, diabetes mortality, patient self-report, patient-reported outcomes, type 1 diabetes, type 2 diabetes, risk stratification, Charlson Comorbidity Index, HbA1c, diabetes complications
- MeSH terms
- Adult, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Male, Retrospective Studies, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.